Reversing Endothelial and Diastolic Dysfunction and Improving Collagen Turnover in Diastolic Heart Failure

Phase 4 Terminated 11 enrolled The Cleveland Clinic

RandomizedParallel-groupTriple-blindTreatment

Summary

The principle aim is to determine the efficacy of eplerenone in patients with diastolic heart failure to reverse cardiac remodeling and to improve diastolic function.

Timeline

Start: 2003-09
Primary completion: 2007-09
Completion: 2007-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Eplerenone	Unknown	50 mg	—

Reversing Endothelial and Diastolic Dysfunction and Improving Collagen Turnover in Diastolic Heart Failure

Summary

Timeline

Drugs

Indications